BI-765049 drug page Clinical trials

Trials with BI-765049

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
6Countries
232Planned patients

Showing 1–2 of 2

A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
Finished Phase 1 135 patients NCT06882746

This study is open to adults with advanced cancer of the colon, rectum, stomach, or pancreas, that is the cancer cannot be removed by surgery or has spread. People can take part in this study if their previous treatment was not successful,…

United States, Germany, Spain Mar 2025 – Sept 2026 Interventional
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Finished Phase 1 97 patients NCT06091930

This is a study in adults from Asia with different types of advanced cancer (solid tumours). People can join the study if they have cancer of the stomach, large bowel and rectum, pancreas, liver, head and neck or non-small cell lung cancer…

China, Japan, South Korea Feb 2024 – Sept 2028 Interventional
Combined with: Ezabenlimab